Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer

  • Authors:
    • Toshihiro Nakao
    • Takashi Iwata
    • Masanori Hotchi
    • Kozo Yoshikawa
    • Jun Higashijima
    • Masaaki Nishi
    • Chie Takasu
    • Shohei Eto
    • Hiroki Teraoku
    • Mitsuo Shimada
  • View Affiliations

  • Published online on: August 10, 2015     https://doi.org/10.3892/or.2015.4196
  • Pages: 1961-1967
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Preoperative chemoradiotherapy (CRT) has become the standard treatment for patients with locally advanced rectal cancer. However, no specific biomarker has been identified to predict a response to preoperative CRT. The aim of the present study was to assess the gene expression patterns of patients with advanced rectal cancer to predict their responses to preoperative CRT. Fifty-nine rectal cancer patients were subjected to preoperative CRT. Patients were randomly assigned to receive CRT with tegafur/gimeracil/oteracil (S-1 group, n=30) or tegafur-uracil (UFT group, n=29). Gene expression changes were studied with cDNA and miRNA microarray. The association between gene expression and response to CRT was evaluated. cDNA microarray showed that 184 genes were significantly differentially expressed between the responders and the non‑responders in the S-1 group. Comparatively, 193 genes were significantly differentially expressed in the responders in the UFT group. TBX18 upregulation was common to both groups whereas BTNL8, LOC375010, ADH1B, HRASLS2, LOC284232, GCNT3 and ALDH1A2 were significantly differentially lower in both groups when compared with the non-responders. Using miRNA microarray, we found that 7 and 16 genes were significantly differentially expressed between the responders and non-responders in the S-1 and UFT groups, respectively. miR-223 was significantly higher in the responders in the S-1 group and tended to be higher in the responders in the UFT group. The present study identified several genes likely to be useful for establishing individualized therapies for patients with rectal cancer.
View Figures
View References

Related Articles

Journal Cover

October 2015
Volume 34 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Nakao, T., Iwata, T., Hotchi, M., Yoshikawa, K., Higashijima, J., Nishi, M. ... Shimada, M. (2015). Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer. Oncology Reports, 34, 1961-1967. https://doi.org/10.3892/or.2015.4196
MLA
Nakao, T., Iwata, T., Hotchi, M., Yoshikawa, K., Higashijima, J., Nishi, M., Takasu, C., Eto, S., Teraoku, H., Shimada, M."Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer". Oncology Reports 34.4 (2015): 1961-1967.
Chicago
Nakao, T., Iwata, T., Hotchi, M., Yoshikawa, K., Higashijima, J., Nishi, M., Takasu, C., Eto, S., Teraoku, H., Shimada, M."Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer". Oncology Reports 34, no. 4 (2015): 1961-1967. https://doi.org/10.3892/or.2015.4196